Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06190626 · ClinicalTrials.gov registry record

Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder

A clinical trial of Zellweger Spectrum Disorder, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre.

Recruiting
Registry status
30
Enrollment target
3
Study locations

NCT06190626 is a study of Zellweger Spectrum Disorder that is actively recruiting participants, run by McGill University Health Centre/Research Institute of the McGill University Health Centre. The registered enrollment target is 30 participants. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06190626, a study of Zellweger Spectrum Disorder, is actively recruiting participants, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre.

RECRUITING
Registry status
30 participants
Enrollment target
3
Study locations

Study Summary

The goal of this observational study is to define the course of the retinal degeneration in a ZSD patient cohort. The objective of this study is to gather information so the investigators can: 1. define the course of the retinal degeneration in a ZSD patient cohort with retinal degeneration 2. define what tests best monitor the progression of the retinal degeneration 3. generate prognostic information about vision loss in ZSD. At each yearly visit, the participants will answer a functional vision questionnaire, have a physical evaluation, blood test, and participate in a variety of vision tests. The investigators will also collect pertinent medical history. Participants will travel to study site. The study will provide financial support for board and travel.

Study Locations (3)

New York

  • University of Rochester Medical Center/Flaum Eye Institute - Rochester

Alberta

  • Eye Institute of Alberta - Edmonton

Quebec

  • Research Institute-McGill University Health Center - Montreal

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-12-18
Est. Completion 2029-01-01

What the Registry Record Tells You About NCT06190626

The ClinicalTrials.gov registry entry for NCT06190626 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is McGill University Health Centre/Research Institute of the McGill University Health Centre, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Zellweger Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT06190626 reports 3 study locations spanning 3 distinct geographic areas - top geographies include New York, Alberta, Quebec.

Frequently Asked Questions

What is clinical trial NCT06190626 about?

NCT06190626 is a clinical study titled "Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder". The goal of this observational study is to define the course of the retinal degeneration in a ZSD patient cohort. The objective of this study is to gather information so the investigators can: 1. define the course of the retinal degeneration in a ZSD patient cohort with retinal degeneration 2. def...

What is the current status of trial NCT06190626?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2023-12-18. Estimated completion is 2029-01-01.

What conditions does trial NCT06190626 study?

This clinical trial studies the following conditions: Zellweger Spectrum Disorder.

Who is sponsoring clinical trial NCT06190626?

This trial is sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06190626 being conducted?

This trial has 3 study locations across New York, Alberta, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.